APO Research
Talk to an analyst

APO RESEARCH · REPORT

Microarray-based Non-Invasive Prenatal Testing

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Microarray-based Non-Invasive Prenatal Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

3 May 2026192 pages

Choose your research edition.

Industry ResearchMicroarray-based Non-Invasive Prenatal Testing Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Microarray-based Non-Invasive Prenatal Testing Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Microarray-based Non-Invasive Prenatal Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Microarray-based Non-Invasive Prenatal Testing Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Microarray-based Non-Invasive Prenatal Testing Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Microarray-based Non-Invasive Prenatal Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Microarray-based Non-Invasive Prenatal Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Microarray-based Non-Invasive Prenatal Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Microarray-based Non-Invasive Prenatal Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Microarray-based Non-Invasive Prenatal Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Microarray-based Non-Invasive Prenatal Testing include Agilent Technologies, Ariosa Diagnostics (Roche), BGI Group, Eurofins LifeCodexx GmbH, Illumina, Laboratory Corporation of America, Myriad Genetics, Natera and PerkinElmer Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Microarray-based Non-Invasive Prenatal Testing market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Microarray-based Non-Invasive Prenatal Testing and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Microarray-based Non-Invasive Prenatal Testing revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Microarray-based Non-Invasive Prenatal Testing market size, projected growth trends, production technologies, key applications, and end-use industries.

Microarray-based Non-Invasive Prenatal Testing Segment by Company

Agilent Technologies

Ariosa Diagnostics (Roche)

BGI Group

Eurofins LifeCodexx GmbH

Illumina

Laboratory Corporation of America

Myriad Genetics

Natera

PerkinElmer Inc

Quest Diagnostics

Sequenom

Microarray-based Non-Invasive Prenatal Testing Segment by Type

Trisomy Detection

Microdeletion Syndromes

Other

Microarray-based Non-Invasive Prenatal Testing Segment by Application

Hospitals & Clinics

Independent Laboratories

Microarray-based Non-Invasive Prenatal Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Microarray-based Non-Invasive Prenatal Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Microarray-based Non-Invasive Prenatal Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Microarray-based Non-Invasive Prenatal Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Microarray-based Non-Invasive Prenatal Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Microarray-based Non-Invasive Prenatal Testing industry.

Chapter 3: Detailed analysis of Microarray-based Non-Invasive Prenatal Testing companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Microarray-based Non-Invasive Prenatal Testingrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Microarray-based Non-Invasive Prenatal Testing Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Trisomy Detection Table 3. Key Players of Microdeletion Syndromes Table 4. Key Players of Other Table 4. Global Microarray-based Non-Invasive Prenatal Testing Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospitals & Clinics Table 6. Key Players of Independent Laboratories Table 7. Global Microarray-based Non-Invasive Prenatal Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 8. Global Microarray-based Non-Invasive Prenatal Testing Market Size by Region (2021-2026) & (US$ Million) Table 9. Global Microarray-based Non-Invasive Prenatal Testing Market Share by Region (2021-2026) Table 10. Global Microarray-based Non-Invasive Prenatal Testing Market Size by Region (2027-2032) & (US$ Million) Table 11. Global Microarray-based Non-Invasive Prenatal Testing Market Share by Region (2027-2032) Table 12. Microarray-based Non-Invasive Prenatal Testing Industry Trends Table 13. Microarray-based Non-Invasive Prenatal Testing Industry Drivers Table 14. Microarray-based Non-Invasive Prenatal Testing Industry Opportunities and Challenges Table 15. Microarray-based Non-Invasive Prenatal Testing Industry Restraints Table 16. Global Microarray-based Non-Invasive Prenatal Testing Revenue by Company (US$ Million) & (2021-2026) Table 17. Global Microarray-based Non-Invasive Prenatal Testing Revenue Market Share by Company (2021-2026) Table 18. Global Microarray-based Non-Invasive Prenatal Testing Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 19. Global Microarray-based Non-Invasive Prenatal Testing Key Company Head Office and Area Served Table 20. Global Microarray-based Non-Invasive Prenatal Testing Company, Product Type & Application Table 21. Global Microarray-based Non-Invasive Prenatal Testing Company Establishment Date Table 22. Global Company Market Concentration Ratio (CR5 and HHI) Table 23. Global Microarray-based Non-Invasive Prenatal Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 24. Global Microarray-based Non-Invasive Prenatal Testing Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Microarray-based Non-Invasive Prenatal Testing Market Size by Type (2021-2026) & (US$ Million) Table 26. Global Microarray-based Non-Invasive Prenatal Testing Market Size by Type (2027-2032) & (US$ Million) Table 27. Global Microarray-based Non-Invasive Prenatal Testing Revenue Market Share by Type (2021-2026) Table 28. Global Microarray-based Non-Invasive Prenatal Testing Revenue Market Share by Type (2027-2032) Table 29. Global Microarray-based Non-Invasive Prenatal Testing Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Microarray-based Non-Invasive Prenatal Testing Market Size by Application (2021-2026) & (US$ Million) Table 31. Global Microarray-based Non-Invasive Prenatal Testing Market Size by Application (2027-2032) & (US$ Million) Table 32. Global Microarray-based Non-Invasive Prenatal Testing Revenue Market Share by Application (2021-2026) Table 33. Global Microarray-based Non-Invasive Prenatal Testing Revenue Market Share by Application (2027-2032) Table 34. Agilent Technologies Company Information Table 35. Agilent Technologies Business Overview Table 36. Agilent Technologies Microarray-based Non-Invasive Prenatal Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Agilent Technologies Microarray-based Non-Invasive Prenatal Testing Product Portfolio Table 38. Agilent Technologies Recent Development Table 39. Ariosa Diagnostics (Roche) Company Information Table 40. Ariosa Diagnostics (Roche) Business Overview Table 41. Ariosa Diagnostics (Roche) Microarray-based Non-Invasive Prenatal Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Ariosa Diagnostics (Roche) Microarray-based Non-Invasive Prenatal Testing Product Portfolio Table 43. Ariosa Diagnostics (Roche) Recent Development Table 44. BGI Group Company Information Table 45. BGI Group Business Overview Table 46. BGI Group Microarray-based Non-Invasive Prenatal Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. BGI Group Microarray-based Non-Invasive Prenatal Testing Product Portfolio Table 48. BGI Group Recent Development Table 49. Eurofins LifeCodexx GmbH Company Information Table 50. Eurofins LifeCodexx GmbH Business Overview Table 51. Eurofins LifeCodexx GmbH Microarray-based Non-Invasive Prenatal Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Eurofins LifeCodexx GmbH Microarray-based Non-Invasive Prenatal Testing Product Portfolio Table 53. Eurofins LifeCodexx GmbH Recent Development Table 54. Illumina Company Information Table 55. Illumina Business Overview Table 56. Illumina Microarray-based Non-Invasive Prenatal Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Illumina Microarray-based Non-Invasive Prenatal Testing Product Portfolio Table 58. Illumina Recent Development Table 59. Laboratory Corporation of America Company Information Table 60. Laboratory Corporation of America Business Overview Table 61. Laboratory Corporation of America Microarray-based Non-Invasive Prenatal Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Laboratory Corporation of America Microarray-based Non-Invasive Prenatal Testing Product Portfolio Table 63. Laboratory Corporation of America Recent Development Table 64. Myriad Genetics Company Information Table 65. Myriad Genetics Business Overview Table 66. Myriad Genetics Microarray-based Non-Invasive Prenatal Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Myriad Genetics Microarray-based Non-Invasive Prenatal Testing Product Portfolio Table 68. Myriad Genetics Recent Development Table 69. Natera Company Information Table 70. Natera Business Overview Table 71. Natera Microarray-based Non-Invasive Prenatal Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Natera Microarray-based Non-Invasive Prenatal Testing Product Portfolio Table 73. Natera Recent Development Table 74. PerkinElmer Inc Company Information Table 75. PerkinElmer Inc Business Overview Table 76. PerkinElmer Inc Microarray-based Non-Invasive Prenatal Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. PerkinElmer Inc Microarray-based Non-Invasive Prenatal Testing Product Portfolio Table 78. PerkinElmer Inc Recent Development Table 79. Quest Diagnostics Company Information Table 80. Quest Diagnostics Business Overview Table 81. Quest Diagnostics Microarray-based Non-Invasive Prenatal Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Quest Diagnostics Microarray-based Non-Invasive Prenatal Testing Product Portfolio Table 83. Quest Diagnostics Recent Development Table 84. Sequenom Company Information Table 85. Sequenom Business Overview Table 86. Sequenom Microarray-based Non-Invasive Prenatal Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. Sequenom Microarray-based Non-Invasive Prenatal Testing Product Portfolio Table 88. Sequenom Recent Development Table 89. North America Microarray-based Non-Invasive Prenatal Testing Market Size by Type (2021-2026) & (US$ Million) Table 90. North America Microarray-based Non-Invasive Prenatal Testing Market Size by Type (2027-2032) & (US$ Million) Table 91. North America Microarray-based Non-Invasive Prenatal Testing Market Size by Application (2021-2026) & (US$ Million) Table 92. North America Microarray-based Non-Invasive Prenatal Testing Market Size by Application (2027-2032) & (US$ Million) Table 93. North America Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 94. North America Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2021-2026) Table 95. North America Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2027-2032) Table 96. Europe Microarray-based Non-Invasive Prenatal Testing Market Size by Type (2021-2026) & (US$ Million) Table 97. Europe Microarray-based Non-Invasive Prenatal Testing Market Size by Type (2027-2032) & (US$ Million) Table 98. Europe Microarray-based Non-Invasive Prenatal Testing Market Size by Application (2021-2026) & (US$ Million) Table 99. Europe Microarray-based Non-Invasive Prenatal Testing Market Size by Application (2027-2032) & (US$ Million) Table 100. Europe Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. Europe Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2021-2026) Table 102. Europe Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2027-2032) Table 103. China Microarray-based Non-Invasive Prenatal Testing Market Size by Type (2021-2026) & (US$ Million) Table 104. China Microarray-based Non-Invasive Prenatal Testing Market Size by Type (2027-2032) & (US$ Million) Table 105. China Microarray-based Non-Invasive Prenatal Testing Market Size by Application (2021-2026) & (US$ Million) Table 106. China Microarray-based Non-Invasive Prenatal Testing Market Size by Application (2027-2032) & (US$ Million) Table 107. Asia Microarray-based Non-Invasive Prenatal Testing Market Size by Type (2021-2026) & (US$ Million) Table 108. Asia Microarray-based Non-Invasive Prenatal Testing Market Size by Type (2027-2032) & (US$ Million) Table 109. Asia Microarray-based Non-Invasive Prenatal Testing Market Size by Application (2021-2026) & (US$ Million) Table 110. Asia Microarray-based Non-Invasive Prenatal Testing Market Size by Application (2027-2032) & (US$ Million) Table 111. Asia Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 112. Asia Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2021-2026) Table 113. Asia Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2027-2032) Table 114. South America, Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Size by Type (2021-2026) & (US$ Million) Table 115. South America, Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Size by Type (2027-2032) & (US$ Million) Table 116. South America, Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Size by Application (2021-2026) & (US$ Million) Table 117. South America, Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Size by Application (2027-2032) & (US$ Million) Table 118. South America, Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 119. South America, Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2021-2026) Table 120. South America, Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2027-2032) Table 121. Research Programs/Design for This Report Table 122. Authors List of This Report Table 123. Secondary Sources Table 124. Primary Sources List of Figures Figure 1. Microarray-based Non-Invasive Prenatal Testing Product Image Figure 2. Global Microarray-based Non-Invasive Prenatal Testing Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Microarray-based Non-Invasive Prenatal Testing Market Share by Type: 2025 VS 2032 Figure 4. Trisomy Detection Image Figure 5. Microdeletion Syndromes Image Figure 6. Other Image Figure 7. Global Microarray-based Non-Invasive Prenatal Testing Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Microarray-based Non-Invasive Prenatal Testing Market Share by Application: 2025 VS 2032 Figure 9. Hospitals & Clinics Image Figure 10. Independent Laboratories Image Figure 11. Global Microarray-based Non-Invasive Prenatal Testing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Microarray-based Non-Invasive Prenatal Testing Market Size (2021-2032) & (US$ Million) Figure 13. Global Microarray-based Non-Invasive Prenatal Testing Market Share by Region: 2025 VS 2032 Figure 14. Years Considered Figure 15. Global Microarray-based Non-Invasive Prenatal Testing Market Share by Players in 2025 Figure 16. Global Top 5 and 10 Microarray-based Non-Invasive Prenatal Testing Players Market Share by Revenue in 2025 Figure 17. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Microarray-based Non-Invasive Prenatal Testing Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Microarray-based Non-Invasive Prenatal Testing Revenue Market Share by Type (2021-2032) Figure 20. Global Microarray-based Non-Invasive Prenatal Testing Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Microarray-based Non-Invasive Prenatal Testing Revenue Market Share by Application (2021-2032) Figure 22. North America Microarray-based Non-Invasive Prenatal Testing Market Size (2021-2032) & (US$ Million) Figure 23. North America Microarray-based Non-Invasive Prenatal Testing Market Share by Type (2021-2032) Figure 24. North America Microarray-based Non-Invasive Prenatal Testing Market Share by Application (2021-2032) Figure 25. North America Microarray-based Non-Invasive Prenatal Testing Market Share by Country (2021-2032) Figure 26. United States Microarray-based Non-Invasive Prenatal Testing Market Size (2021-2032) & (US$ Million) Figure 27. Canada Microarray-based Non-Invasive Prenatal Testing Market Size (2021-2032) & (US$ Million) Figure 28. Mexico Microarray-based Non-Invasive Prenatal Testing Market Size (2021-2032) & (US$ Million) Figure 29. Europe Microarray-based Non-Invasive Prenatal Testing Market Size (2021-2032) & (US$ Million) Figure 30. Europe Microarray-based Non-Invasive Prenatal Testing Market Share by Type (2021-2032) Figure 31. Europe Microarray-based Non-Invasive Prenatal Testing Market Share by Application (2021-2032) Figure 32. Europe Microarray-based Non-Invasive Prenatal Testing Market Share by Country (2021-2032) Figure 33. Germany Microarray-based Non-Invasive Prenatal Testing Market Size (2021-2032) & (US$ Million) Figure 34. France Microarray-based Non-Invasive Prenatal Testing Market Size (2021-2032) & (US$ Million) Figure 35. U.K. Microarray-based Non-Invasive Prenatal Testing Market Size (2021-2032) & (US$ Million) Figure 36. Italy Microarray-based Non-Invasive Prenatal Testing Market Size (2021-2032) & (US$ Million) Figure 37. Russia Microarray-based Non-Invasive Prenatal Testing Market Size (2021-2032) & (US$ Million) Figure 38. Nordic Countries Microarray-based Non-Invasive Prenatal Testing Market Size (2021-2032) & (US$ Million) Figure 39. China Microarray-based Non-Invasive Prenatal Testing Market Size (2021-2032) & (US$ Million) Figure 40. China Microarray-based Non-Invasive Prenatal Testing Market Share by Type (2021-2032) Figure 41. China Microarray-based Non-Invasive Prenatal Testing Market Share by Application (2021-2032) Figure 42. Asia Microarray-based Non-Invasive Prenatal Testing Market Size (2021-2032) & (US$ Million) Figure 43. Asia Microarray-based Non-Invasive Prenatal Testing Market Share by Type (2021-2032) Figure 44. Asia Microarray-based Non-Invasive Prenatal Testing Market Share by Application (2021-2032) Figure 45. Asia Microarray-based Non-Invasive Prenatal Testing Market Share by Country (2021-2032) Figure 46. Japan Microarray-based Non-Invasive Prenatal Testing Market Size (2021-2032) & (US$ Million) Figure 47. South Korea Microarray-based Non-Invasive Prenatal Testing Market Size (2021-2032) & (US$ Million) Figure 48. Taiwan Microarray-based Non-Invasive Prenatal Testing Market Size (2021-2032) & (US$ Million) Figure 49. Southeast Asia Microarray-based Non-Invasive Prenatal Testing Market Size (2021-2032) & (US$ Million) Figure 50. India Microarray-based Non-Invasive Prenatal Testing Market Size (2021-2032) & (US$ Million) Figure 51. Australia Microarray-based Non-Invasive Prenatal Testing Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Share by Type (2021-2032) Figure 54. South America, Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Share by Application (2021-2032) Figure 55. South America, Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Share by Country (2021-2032) Figure 56. Brazil Microarray-based Non-Invasive Prenatal Testing Market Size (2021-2032) & (US$ Million) Figure 57. South Africa Microarray-based Non-Invasive Prenatal Testing Market Size (2021-2032) & (US$ Million) Figure 58. Saudi Arabia Microarray-based Non-Invasive Prenatal Testing Market Size (2021-2032) & (US$ Million) Figure 59. Turkey Microarray-based Non-Invasive Prenatal Testing Market Size (2021-2032) & (US$ Million) Figure 60. Argentina Microarray-based Non-Invasive Prenatal Testing Market Size (2021-2032) & (US$ Million) Figure 61. UAE Microarray-based Non-Invasive Prenatal Testing Market Size (2021-2032) & (US$ Million) Figure 62. Egypt Microarray-based Non-Invasive Prenatal Testing Market Size (2021-2032) & (US$ Million) Figure 63. Chile Microarray-based Non-Invasive Prenatal Testing Market Size (2021-2032) & (US$ Million) Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • Trisomy Detection
  • Microdeletion Syndromes
  • Other
Applications
  • Hospitals & Clinics
  • Independent Laboratories
Companies covered
  • Agilent Technologies
  • Ariosa Diagnostics (Roche)
  • BGI Group
  • Eurofins LifeCodexx GmbH
  • Illumina
  • Laboratory Corporation of America
  • Myriad Genetics
  • Natera
  • PerkinElmer Inc
  • Quest Diagnostics
  • Sequenom

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Microarray-based Non-Invasive Prenatal Testing Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Trisomy Detection
  5. 1.2.3 Microdeletion Syndromes
  6. 1.2.4 Other
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Microarray-based Non-Invasive Prenatal Testing Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Hospitals & Clinics
  10. 1.3.3 Independent Laboratories
  11. 1.4 Global Market Growth Prospects
  12. 1.5 Global Microarray-based Non-Invasive Prenatal Testing Growth Trends by Region
  13. 1.5.1 Global Microarray-based Non-Invasive Prenatal Testing Market Size by Region: 2021 VS 2025 VS 2032
  14. 1.5.2 Microarray-based Non-Invasive Prenatal Testing Market Size by Region (2021-2026)
  15. 1.5.3 Microarray-based Non-Invasive Prenatal Testing Market Size by Region (2027-2032)
  16. 1.6 Assumptions and Limitations
  17. 1.7 Study Goals and Objectives
  18. 1.8 Years Considered
2 Global Microarray-based Non-Invasive Prenatal Testing Market Dynamics
  1. 2.1 Microarray-based Non-Invasive Prenatal Testing Industry Trends
  2. 2.2 Microarray-based Non-Invasive Prenatal Testing Industry Drivers
  3. 2.3 Microarray-based Non-Invasive Prenatal Testing Industry Opportunities and Challenges
  4. 2.4 Microarray-based Non-Invasive Prenatal Testing Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Microarray-based Non-Invasive Prenatal Testing Revenue by Company (2021-2026)
  2. 3.2 Global Microarray-based Non-Invasive Prenatal Testing Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Microarray-based Non-Invasive Prenatal Testing Key Company Head office and Area Served
  4. 3.4 Global Microarray-based Non-Invasive Prenatal Testing Company, Product Type & Application
  5. 3.5 Global Microarray-based Non-Invasive Prenatal Testing Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Microarray-based Non-Invasive Prenatal Testing Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Microarray-based Non-Invasive Prenatal Testing Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Microarray-based Non-Invasive Prenatal Testing Tier 1, Tier 2, and Tier 3
4 Microarray-based Non-Invasive Prenatal Testing Market by Type
  1. 4.1 Global Microarray-based Non-Invasive Prenatal Testing Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Microarray-based Non-Invasive Prenatal Testing Market Size by Type (2021-2032)
  3. 4.3 Global Microarray-based Non-Invasive Prenatal Testing Market Size Share by Type (2021-2032)
5 Microarray-based Non-Invasive Prenatal Testing Market by Application
  1. 5.1 Global Microarray-based Non-Invasive Prenatal Testing Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Microarray-based Non-Invasive Prenatal Testing Market Size by Application (2021-2032)
  3. 5.3 Global Microarray-based Non-Invasive Prenatal Testing Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Agilent Technologies
  2. 6.1.1 Agilent Technologies Company Information
  3. 6.1.2 Agilent Technologies Business Overview
  4. 6.1.3 Agilent Technologies Microarray-based Non-Invasive Prenatal Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Agilent Technologies Microarray-based Non-Invasive Prenatal Testing Product Portfolio
  6. 6.1.5 Agilent Technologies Recent Developments
  7. 6.2 Ariosa Diagnostics (Roche)
  8. 6.2.1 Ariosa Diagnostics (Roche) Company Information
  9. 6.2.2 Ariosa Diagnostics (Roche) Business Overview
  10. 6.2.3 Ariosa Diagnostics (Roche) Microarray-based Non-Invasive Prenatal Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Ariosa Diagnostics (Roche) Microarray-based Non-Invasive Prenatal Testing Product Portfolio
  12. 6.2.5 Ariosa Diagnostics (Roche) Recent Developments
  13. 6.3 BGI Group
  14. 6.3.1 BGI Group Company Information
  15. 6.3.2 BGI Group Business Overview
  16. 6.3.3 BGI Group Microarray-based Non-Invasive Prenatal Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 BGI Group Microarray-based Non-Invasive Prenatal Testing Product Portfolio
  18. 6.3.5 BGI Group Recent Developments
  19. 6.4 Eurofins LifeCodexx GmbH
  20. 6.4.1 Eurofins LifeCodexx GmbH Company Information
  21. 6.4.2 Eurofins LifeCodexx GmbH Business Overview
  22. 6.4.3 Eurofins LifeCodexx GmbH Microarray-based Non-Invasive Prenatal Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Eurofins LifeCodexx GmbH Microarray-based Non-Invasive Prenatal Testing Product Portfolio
  24. 6.4.5 Eurofins LifeCodexx GmbH Recent Developments
  25. 6.5 Illumina
  26. 6.5.1 Illumina Company Information
  27. 6.5.2 Illumina Business Overview
  28. 6.5.3 Illumina Microarray-based Non-Invasive Prenatal Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Illumina Microarray-based Non-Invasive Prenatal Testing Product Portfolio
  30. 6.5.5 Illumina Recent Developments
  31. 6.6 Laboratory Corporation of America
  32. 6.6.1 Laboratory Corporation of America Company Information
  33. 6.6.2 Laboratory Corporation of America Business Overview
  34. 6.6.3 Laboratory Corporation of America Microarray-based Non-Invasive Prenatal Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Laboratory Corporation of America Microarray-based Non-Invasive Prenatal Testing Product Portfolio
  36. 6.6.5 Laboratory Corporation of America Recent Developments
  37. 6.7 Myriad Genetics
  38. 6.7.1 Myriad Genetics Company Information
  39. 6.7.2 Myriad Genetics Business Overview
  40. 6.7.3 Myriad Genetics Microarray-based Non-Invasive Prenatal Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Myriad Genetics Microarray-based Non-Invasive Prenatal Testing Product Portfolio
  42. 6.7.5 Myriad Genetics Recent Developments
  43. 6.8 Natera
  44. 6.8.1 Natera Company Information
  45. 6.8.2 Natera Business Overview
  46. 6.8.3 Natera Microarray-based Non-Invasive Prenatal Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Natera Microarray-based Non-Invasive Prenatal Testing Product Portfolio
  48. 6.8.5 Natera Recent Developments
  49. 6.9 PerkinElmer Inc
  50. 6.9.1 PerkinElmer Inc Company Information
  51. 6.9.2 PerkinElmer Inc Business Overview
  52. 6.9.3 PerkinElmer Inc Microarray-based Non-Invasive Prenatal Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 PerkinElmer Inc Microarray-based Non-Invasive Prenatal Testing Product Portfolio
  54. 6.9.5 PerkinElmer Inc Recent Developments
  55. 6.10 Quest Diagnostics
  56. 6.10.1 Quest Diagnostics Company Information
  57. 6.10.2 Quest Diagnostics Business Overview
  58. 6.10.3 Quest Diagnostics Microarray-based Non-Invasive Prenatal Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Quest Diagnostics Microarray-based Non-Invasive Prenatal Testing Product Portfolio
  60. 6.10.5 Quest Diagnostics Recent Developments
  61. 6.11 Sequenom
  62. 6.11.1 Sequenom Company Information
  63. 6.11.2 Sequenom Business Overview
  64. 6.11.3 Sequenom Microarray-based Non-Invasive Prenatal Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Sequenom Microarray-based Non-Invasive Prenatal Testing Product Portfolio
  66. 6.11.5 Sequenom Recent Developments
7 North America
  1. 7.1 North America Microarray-based Non-Invasive Prenatal Testing Market Size (2021-2032)
  2. 7.2 North America Microarray-based Non-Invasive Prenatal Testing Market Size by Type
  3. 7.2.1 North America Microarray-based Non-Invasive Prenatal Testing Market Size by Type (2021-2026)
  4. 7.2.2 North America Microarray-based Non-Invasive Prenatal Testing Market Size by Type (2027-2032)
  5. 7.2.3 North America Microarray-based Non-Invasive Prenatal Testing Market Share by Type (2021-2032)
  6. 7.3 North America Microarray-based Non-Invasive Prenatal Testing Market Size by Application
  7. 7.3.1 North America Microarray-based Non-Invasive Prenatal Testing Market Size by Application (2021-2026)
  8. 7.3.2 North America Microarray-based Non-Invasive Prenatal Testing Market Size by Application (2027-2032)
  9. 7.3.3 North America Microarray-based Non-Invasive Prenatal Testing Market Share by Application (2021-2032)
  10. 7.4 North America Microarray-based Non-Invasive Prenatal Testing Market Size by Country
  11. 7.4.1 North America Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2021-2026)
  13. 7.4.3 North America Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2027-2032)
  14. 7.4.4 North America Microarray-based Non-Invasive Prenatal Testing Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Microarray-based Non-Invasive Prenatal Testing Market Size (2021-2032)
  2. 8.2 Europe Microarray-based Non-Invasive Prenatal Testing Market Size by Type
  3. 8.2.1 Europe Microarray-based Non-Invasive Prenatal Testing Market Size by Type (2021-2026)
  4. 8.2.2 Europe Microarray-based Non-Invasive Prenatal Testing Market Size by Type (2027-2032)
  5. 8.2.3 Europe Microarray-based Non-Invasive Prenatal Testing Market Share by Type (2021-2032)
  6. 8.3 Europe Microarray-based Non-Invasive Prenatal Testing Market Size by Application
  7. 8.3.1 Europe Microarray-based Non-Invasive Prenatal Testing Market Size by Application (2021-2026)
  8. 8.3.2 Europe Microarray-based Non-Invasive Prenatal Testing Market Size by Application (2027-2032)
  9. 8.3.3 Europe Microarray-based Non-Invasive Prenatal Testing Market Share by Application (2021-2032)
  10. 8.4 Europe Microarray-based Non-Invasive Prenatal Testing Market Size by Country
  11. 8.4.1 Europe Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2021-2026)
  13. 8.4.3 Europe Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2027-2032)
  14. 8.4.4 Europe Microarray-based Non-Invasive Prenatal Testing Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Microarray-based Non-Invasive Prenatal Testing Market Size (2021-2032)
  2. 9.2 China Microarray-based Non-Invasive Prenatal Testing Market Size by Type
  3. 9.2.1 China Microarray-based Non-Invasive Prenatal Testing Market Size by Type (2021-2026)
  4. 9.2.2 China Microarray-based Non-Invasive Prenatal Testing Market Size by Type (2027-2032)
  5. 9.2.3 China Microarray-based Non-Invasive Prenatal Testing Market Share by Type (2021-2032)
  6. 9.3 China Microarray-based Non-Invasive Prenatal Testing Market Size by Application
  7. 9.3.1 China Microarray-based Non-Invasive Prenatal Testing Market Size by Application (2021-2026)
  8. 9.3.2 China Microarray-based Non-Invasive Prenatal Testing Market Size by Application (2027-2032)
  9. 9.3.3 China Microarray-based Non-Invasive Prenatal Testing Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Microarray-based Non-Invasive Prenatal Testing Market Size (2021-2032)
  2. 10.2 Asia Microarray-based Non-Invasive Prenatal Testing Market Size by Type
  3. 10.2.1 Asia Microarray-based Non-Invasive Prenatal Testing Market Size by Type (2021-2026)
  4. 10.2.2 Asia Microarray-based Non-Invasive Prenatal Testing Market Size by Type (2027-2032)
  5. 10.2.3 Asia Microarray-based Non-Invasive Prenatal Testing Market Share by Type (2021-2032)
  6. 10.3 Asia Microarray-based Non-Invasive Prenatal Testing Market Size by Application
  7. 10.3.1 Asia Microarray-based Non-Invasive Prenatal Testing Market Size by Application (2021-2026)
  8. 10.3.2 Asia Microarray-based Non-Invasive Prenatal Testing Market Size by Application (2027-2032)
  9. 10.3.3 Asia Microarray-based Non-Invasive Prenatal Testing Market Share by Application (2021-2032)
  10. 10.4 Asia Microarray-based Non-Invasive Prenatal Testing Market Size by Country
  11. 10.4.1 Asia Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2021-2026)
  13. 10.4.3 Asia Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2027-2032)
  14. 10.4.4 Asia Microarray-based Non-Invasive Prenatal Testing Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst